Deutsche Bank’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,451
| Closed | -$53K | – | 4007 |
|
|
2022
Q1 | $53K | Sell |
1,451
-1,111
| -43% | -$40.6K | ﹤0.01% | 3741 |
|
|
2021
Q4 | $137K | Buy |
2,562
+2,235
| +683% | +$120K | ﹤0.01% | 3514 |
|
|
2021
Q3 | $24K | Sell |
327
-87
| -21% | -$6.39K | ﹤0.01% | 4061 |
|
|
2021
Q2 | $348K | Buy |
414
+288
| +229% | +$242K | ﹤0.01% | 3436 |
|
|
2021
Q1 | $108K | Hold |
126
| – | – | ﹤0.01% | 3876 |
|
|
2020
Q4 | $114K | Hold |
126
| – | – | ﹤0.01% | 3704 |
|
|
2020
Q3 | $152K | Sell |
126
-9
| -7% | -$10.9K | ﹤0.01% | 3313 |
|
|
2020
Q2 | $49K | Sell |
135
-9
| -6% | -$3.27K | ﹤0.01% | 3771 |
|
|
2020
Q1 | $66K | Sell |
144
-73
| -34% | -$33.5K | ﹤0.01% | 3359 |
|
|
2019
Q4 | $42K | Sell |
217
-212
| -49% | -$41K | ﹤0.01% | 3919 |
|
|
2019
Q3 | $105K | Sell |
429
-249
| -37% | -$60.9K | ﹤0.01% | 3450 |
|
|
2019
Q2 | $1.7M | Buy |
678
+527
| +349% | +$1.32M | ﹤0.01% | 2494 |
|
|
2019
Q1 | $612K | Buy |
151
+94
| +165% | +$381K | ﹤0.01% | 3288 |
|
|
2018
Q4 | $174K | Sell |
57
-81
| -59% | -$247K | ﹤0.01% | 3844 |
|
|
2018
Q3 | $805K | Buy |
138
+33
| +31% | +$193K | ﹤0.01% | 3453 |
|
|
2018
Q2 | $369K | Buy |
105
+37
| +54% | +$130K | ﹤0.01% | 3920 |
|
|
2018
Q1 | $302K | Sell |
68
-47
| -41% | -$209K | ﹤0.01% | 3884 |
|
|
2017
Q4 | $440K | Buy |
115
+95
| +475% | +$363K | ﹤0.01% | 3578 |
|
|
2017
Q3 | $93K | Sell |
20
-8
| -29% | -$37.2K | ﹤0.01% | 3983 |
|
|
2017
Q2 | $126K | Buy |
+28
| New | +$126K | ﹤0.01% | 3939 |
|